- Report
- March 2025
- 281 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 184 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 214 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 193 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 193 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 193 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 150 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 182 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 214 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 442 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 415 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 369 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 174 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 209 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 174 Pages
Global
From €5181EUR$5,450USD£4,353GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more